companydata.dkcompanydata.dk

PHARMA-SKAN ApS: Financial statements 2024

CVR: 16275247

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 15,271,780 and a net result of DKK 11,288,304 compared with DKK 11,498,311 the year before. That is a decrease of 0.2% compared with the year before. Equity in the 2024 report amounted to DKK 19,167,815. The solvency ratio was 82.2%. The company had 13 employees in the financial year.

Gross Profit
DKK 15,271,780
Profit/Loss
DKK 11,288,304
Equity
DKK 19,167,815
Total Assets
DKK 23,309,969
Employees
13

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-15.3 mio.11.3 mio.19.2 mio.13
2023-15.3 mio.11.5 mio.19.9 mio.14
2022-14.8 mio.10.9 mio.18.9 mio.13
2021-12.4 mio.9.1 mio.17 mio.13
2020-12.6 mio.9.3 mio.17.9 mio.14

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

PHARMA-SKAN ApS: The 2023 annual report is outJun 11, 2024

PHARMA-SKAN ApS has published its annual report for 2023. Gross profit came to DKK 15,308,053, and the net result was DKK 11,498,311.

About PHARMA-SKAN ApS

PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.

Source: annual report 2025, Danish Business Authority